Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Jadidi-Niaragh, Farhad  [Clear All Filters]
2015
Gharibi T, Ahmadi M, Seyfizadeh N, Jadidi-Niaragh F, Yousefi M. Immunomodulatory characteristics of mesenchymal stem cells and their role in the treatment of Multiple Sclerosis. Cell Immunol. 2015;293(2):113-121.
2018
Eghbal-Fard S, Yousefi M, Heydarlou H, Ahmadi M, Taghavi S, Movasaghpour A, Jadidi-Niaragh F, Yousefi B, Dolati S, Hojjat-Farsangi M, et al. The imbalance of Th17/Treg axis involved in the pathogenesis of preeclampsia. J Cell Physiol. 2018.
Jafarzadeh S, Ahmadi M, Dolati S, Aghebati-Maleki L, Eghbal-Fard S, Kamrani A, Behrad B, Roshangar L, Jadidi-Niaragh F, Yousefi B, et al. Intravenous immunoglobulin G treatment increases live birth rate in women with recurrent miscarriage and modulates regulatory and exhausted regulatory T cells frequency and function. J Cell Biochem. 2018.
Ghaebi M, Abdolmohammadi-Vahid S, Ahmadi M, Eghbal-Fard S, Dolati S, Nouri M, Talebi M, Hamdi K, Marofi F, Aghebati-Maleki L, et al. T cell Subsets in Peripheral Blood of Women with Recurrent Implantation Failure. J Reprod Immunol. 2018;131:21-29.
2019
Hassannia H, Chaleshtari MGhasemi, Atyabi F, Nosouhian M, Masjedi A, Hojjat-Farsangi M, Namdar A, Azizi G, Mohammadi H, Ghalamfarsa G, et al. Blockage of immune checkpoint molecules increases T cell priming potential of dendritic cell vaccine. Immunology. 2019.
Hallaj S, Meshkini F, Chaleshtari MGhasemi, Ghorbani A, Namdar A, Soleimanpour H, Jadidi-Niaragh F. Conjugated CAR T cell one step beyond conventional CAR T cell for a promising cancer immunotherapy. Cell Immunol. 2019:103963.
Hajizadeh F, Okoye I, Esmaily M, Chaleshtari MGhasemi, Masjedi A, Azizi G, Irandoust M, Ghalamfarsa G, Jadidi-Niaragh F. Hypoxia inducible factors in the tumor microenvironment as therapeutic targets of cancer stem cells. Life Sci. 2019:116952.
Hashemi V, Maleki LAghebati, Esmaily M, Masjedi A, Ghalamfarsa G, Namdar A, Yousefi M, Yousefi B, Jadidi-Niaragh F. Regulatory T cells in breast cancer as a potent anti-cancer therapeutic target. Int Immunopharmacol. 2019;78:106087.
Koushaeian L, Ghorbani F, Ahmadi M, Eghbal-Fard S, Zamani M, Danaii S, Yousefi B, Jadidi-Niaragh F, Hamdi K, Yousefi M. The role of IL-10-producing B cells in Repeated Implantation Failure patients with cellular immune abnormalities. Immunol Lett. 2019.
2020
Salimifard S, Masjedi A, Hojjat-Farsangi M, Ghalamfarsa G, Irandoust M, Azizi G, Mohammadi H, Keramati MReza, Jadidi-Niaragh F. Cancer associated fibroblasts as novel promising therapeutic targets in breast cancer. Pathol Res Pract. 2020:152915.
Kiaee F, Zaki-Dizaji M, Hafezi N, Almasi-Hashiani A, Hamedifar H, Sabzevari A, Shirkani A, Zian Z, Jadidi-Niaragh F, Aghamahdi F, et al. Clinical, Immunologic, and Molecular Spectrum of Patients with Immunodeficiency, Centromeric instability, and Facial anomalies (ICF) syndrome: a Systematic Review. Endocr Metab Immune Disord Drug Targets. 2020.
Nikkhoo A, Rostami N, Farhadi S, Esmaily M, Ardebili SMoghadasza, Atyabi F, Baghaei M, Haghnavaz N, Yousefi M, Aliparasti MReza, et al. Codelivery of STAT3 siRNA and BV6 by carboxymethyl dextran trimethyl chitosan nanoparticles suppresses cancer cell progression. Int J Pharm. 2020:119236.
Pishgahi A, Abolhasan R, Danaii S, Amanifar B, Soltani-Zangbar MSadegh, Zamani M, Kamrani A, Ghorbani F, Mehdizadeh A, Kafil HSamadi, et al. Immunological and oxidative stress biomarkers in Ankylosing Spondylitis patients with or without metabolic syndrome. Cytokine. 2020;128:155002.
Karpisheh V, Afjedi JFakkari, Afjadi MNabi, Haeri MSadat, Sough TSadat Abdp, Asl SHeydarzade, Edalati M, Atyabi F, Masjedi A, Hajizadeh F, et al. Inhibition of HIF-1α/EP4 axis by hyaluronate-trimethyl chitosan-SPION nanoparticles markedly suppresses the growth and development of cancer cells. Int J Biol Macromol. 2020.
Hashemi V, Farhadi S, Chaleshtari MGhasemi, Seashore-Ludlow B, Masjedi A, Hojjat-Farsangi M, Namdar A, Ajjoolabady A, Mohammadi H, Ghalamfarsa G, et al. Nanomedicine for improvement of dendritic cell-based cancer immunotherapy. Int Immunopharmacol. 2020;83:106446.
Hajizadeh F, Ardebili SMoghadasza, Moornani MBaghi, Masjedi A, Atyabi F, Kiani M, Namdar A, Karpisheh V, Izadi S, Baradaran B, et al. Silencing of HIF-1α/CD73 axis by siRNA-loaded TAT-chitosan-spion nanoparticles robustly blocks cancer cell progression. Eur J Pharmacol. 2020:173235.
Masjedi A, Ahmadi A, Atyabi F, Farhadi S, Irandoust M, Khazaei-Poul Y, Chaleshtari MGhasemi, Fathabad MEdalati, Baghaei M, Haghnavaz N, et al. Silencing of IL-6 and STAT3 by siRNA loaded hyaluronate-N,N,N-trimethyl chitosan nanoparticles potently reduces cancer cell progression. Int J Biol Macromol. 2020.
Hashemi V, Ahmadi A, Malakotikhah F, Chaleshtari MGhasemi, Moornani MBaghi, Masjedi A, Sojoodi M, Atyabi F, Nikkhoo A, Rostami N, et al. Silencing of p68 and STAT3 synergistically diminishes cancer progression. Life Sci. 2020:117499.
2021
Budi HSetia, Izadi S, Timoshin A, Asl SHeydarzade, Beyzai B, Ghaderpour A, Alian F, Eshaghi FSadat, Mousavi SMahboubeh, Rafiee B, et al. Blockade of HIF-1α and STAT3 by hyaluronate-conjugated TAT-chitosan-SPION nanoparticles loaded with siRNA molecules prevents tumor growth. Nanomedicine. 2021:102373.
Tahmasebi S, Saeed BQubais, Temirgalieva E, Yumashev AValerievic, El-Esawi MA, Navashenaq JGholizadeh, Valizadeh H, Sadeghi A, Aslani S, Yousefi M, et al. Nanocurcumin improves Treg cell responses in patients with mild and severe SARS-CoV2. Life Sci. 2021:119437.
Kiani FKaroon, Izadi S, Dezfouli EAnsari, Ebrahimi F, Mohammadi M, Chalajour H, Bulus MMortazavi, Esfahani MNasr, Karpisheh V, Khesht AMahmoud Sa, et al. Simultaneous silencing of A2aR and PD-1 as immune checkpoints by siRNA-loaded nanoparticles enhances the immunotherapeutic potential of dendritic cell vaccine in tumor experimental models. Life Sci. 2021:120166.
Vakili-Samiani S, Jalil ATurki, Abdelbasset WKamal, Yumashev AValerievic, Karpisheh V, Jalali P, Adibfar S, Ahmadi M, Feizi AAli Hossei, Jadidi-Niaragh F. Targeting Wee1 kinase as a therapeutic approach in Hematological Malignancies. DNA Repair (Amst). 2021;107:103203.
2022
Yousefzadeh Y, Soltani-Zangbar MSadegh, Kalafi L, Tarbiat A, Farid SShahmohamm, Aghebati-Maleki L, Parhizkar F, Danaii S, Taghavi S, Jadidi-Niaragh F, et al. Evaluation of CD39, CD73, HIF-1α, and their related miRNAs expression in decidua of preeclampsia cases compared to healthy pregnant women. Mol Biol Rep. 2022.
2023
Motallebnezhad M, Hazrati A, Ghaleh HEsmaeili G, Jonaidi-Jafari N, Abbaspour-Aghdam S, Malekpour K, Yousefi M, Kafil HSamadi, Jadidi-Niaragh F, Roshangar L, et al. Exosomes from Adipose Tissue-derived Mesenchymal Stem Cells Induce Regulatory T Cells in COVID-19 Patients. Iran J Allergy Asthma Immunol. 2023;22(3):233-244.
Widjaja G, Jalil ATurki, Rahman HSulaiman, Abdelbasset WKamal, Bokov DO, Bokov DO, Ghaebi M, Marofi F, Navashenaq JGholizadeh, Jadidi-Niaragh F, et al. Expression of concern: "Humoral immune mechanisms involved in protective and pathological immunity during COVID-19" [Hum. Immunol. 82(10) (2021) 733-745]. Hum Immunol. 2023;84(5-7):355.